Breaking News, Financial News

Financial Report: ICON

Revenues up 24% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ICON 4Q Revenues: $300 million (+24%) 4Q Earnings: $20.7 million (earnings were $4.1 million in 4Q11) FY Revenues: $1.1 billion (+18%) FY Earnings: $55.4 million  (+142%) Comments: Operating income for the quarter was $24.4 million, up from $6.6 million in 4Q11, and 8% of revenue. For the year income from operations was $68.0 million and 6% of revenue. Backlog increased 20% for the year to $2.8 billion. For the year restructuring and other charges were $60.4 million, or 5% of revenue....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters